Financial statements Elanda Pharma
Balance sheet of Elanda Pharma
Company age:
Age:
7 y. 5 m. 8 d.
Share capital:
Share capital:
500 000 PLN
Balance sheet data of ELANDA PHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 7 020 344,30 | 7 123 914,41 | 8 890 998,48 | 8 565 644,03 |
| A. Fixed assets | 4 379 220,36 | 4 721 622,35 | 5 115 476,36 | 5 907 816,82 |
| B. Current assets | 2 641 123,94 | 2 402 292,06 | 3 775 522,12 | 2 657 827,21 |
| C. Share capital contributions (basic funds) | - | - | - | 0,00 |
| D. Own shares (stocks) | - | - | - | 0,00 |
| Total liabilities | 7 020 344,40 | 7 123 914,41 | 8 890 998,48 | 8 565 644,03 |
| A. Equity | 1 631 877,40 | 700 364,66 | 142 140,03 | -2 208 265,88 |
| B. Liabilities and provisions for liabilities | 5 388 467,00 | 6 423 549,75 | 8 748 858,45 | 10 773 909,91 |
| I. Long-term liabilities | 4 671 117,11 | 5 311 483,79 | 5 057 526,63 | 6 839 344,77 |
| II. Short-term liabilities | 414 849,87 | 493 472,01 | 2 999 252,20 | 3 001 793,08 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.